Eli Lilly reports strong Q2 2025 growth, driven by Mounjaro & Zepbound. Highlights include increased guidance, pipeline updates, and key clinical milestones.

Sales of Danish drugmaker Novo Nordisk 's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...

India's Divi's Laboratories reported first-quarter profit below estimates on Wednesday, as manufacturers producing generic ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

Hyderabad: Ina major boost to Telangana’s life sciences and innovation ecosystem, global pharmaceutical giant Eli Lilly ...

Hyderabad: Eli Lilly and Company (India) has announced the opening of its new technology and innovation site in Hyderabad; a ...

HYDERABAD: Praising the vision and hard work of IT and Industries Minister D Sridhar Babu, Chief Minister A Revanth Reddy on ...

In the case of the US, there are simply too many variables shaping Indo–US ties. Leadership factors, even if occasionally not ...

US-based pharmaceutical giant Eli Lilly inaugurated its Global Capability Center (GCC) at Gachibowli today, marking a significant milestone for Telangana’s life sciences sector. #Eli Lilly opens GCC ...

Hyderabad: Pharma giant Eli Lilly and Company (India) opened its new technology and innovation centre in Hyderabad's Hitech ...

US-based pharmaceutical giant Eli Lilly inaugurated its new Technology and innovation site in Hyderabad, today to accelerate Global digital innovation.

Eli Lilly and Company opens new technology and innovation site in Hyderabad, India to enhance global operations.